The slip
PARKINSON RECEIPTno. 4139
20 Oct 2026, 10:46 UTCdopamine neurons, braak
predictionKCNN4 in dopamine neurons tracks Braak Lewy-body stage
registeredb67924780123de0c
discovery-0.26 p=0.502 n=9
replication-0.10 p=0.807 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.26, p 0.502)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT5bae6b4abf4c43df0fca1ea9…
follows 421eab09d27e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4139: KCNN4 in dopamine neurons, braak
- power
- full sample -0.21 (p 0.413, n 18), 95% CI -0.61 to +0.29. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.22 (p 0.384, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.38 (p 0.125, n 18). could be the mix.
- skeptic
- leave-one-out range -0.35 to -0.11, sign flips 0; without severely affected donors -0.21 (p 0.413, n 18). fragile.
- cell type
- strongest in microglia: -0.63 (p 0.0051, n 18) vs -0.21 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KCNN4 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up KCNN4 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.55 p 0.051 (needs p < 4.8e-4)